I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Novel infusion strategy reduces severe adverse events cause..:
Amalia Varo
;
Alicia Castañeda
;
Saray Chamorro
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1164949/full. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1164949
RT Journal T1
Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:977115e7713b494f942e028d18265d09&Exemplar=1&LAN=DE A1 Amalia Varo A1 Alicia Castañeda A1 Saray Chamorro A1 Juan Pablo Muñoz A1 Maite Gorostegui A1 Mónica S. Celma A1 Sandra Lopez A1 Margarida Simao A1 Sara Perez-Jaume A1 Jaume Mora PB Frontiers Media S.A. YR 2023 K1 neuroblastoma K1 immunotherapy K1 adverse events K1 GD2 monoclonal antibody K1 naxitamab K1 pharmacokinetics K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1164949/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1164949 DO https://doi.org/10.3389/fonc.2023.1164949 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)